Mirae Asset Global Investments Co., Ltd. Hutchmed (China) LTD Transaction History

Mirae Asset Global Investments Co., Ltd.

$28 Billion
Q2 2025

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,198 shares of HCM stock, worth $21,252. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,198

Previous 1,038 15.41%

Holding current value

$21,252

Previous $15,000 20.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 21, 2025	BUY	$11.81 - $17.72 $1,889 - $2,835	160 Added 15.41%	1,198 $18,000
Q1 2025 Apr 24, 2025	BUY	$13.09 - $16.75 $52 - $67	4 Added 0.39%	1,038 $15,000
Q4 2024 Jan 27, 2025	SELL	$14.25 - $21.35 $1,254 - $1,878	-88 Reduced 7.84%	1,034 $14,000
Q3 2024 Oct 23, 2024	BUY	$16.03 - $20.31 $3,141 - $3,980	196 Added 21.17%	1,122 $21,000
Q2 2024 Jul 30, 2024	BUY	$16.36 - $21.78 $15,149 - $20,168	926 New	926 $15,000
Q4 2022 Feb 09, 2023	SELL	$7.65 - $15.51 $66,256 - $134,332	-8,661 Reduced 3.28%	255,559 $3.78 Million
Q3 2022 Nov 10, 2022	BUY	$8.63 - $15.52 $967,569 - $1.74 Million	112,117 Added 73.71%	264,220 $2.34 Million
Q2 2022 Jul 26, 2022	SELL	$8.59 - $20.77 $98,742 - $238,751	-11,495 Reduced 7.03%	152,103 $1.92 Million
Q1 2022 May 10, 2022	BUY	$15.52 - $35.65 $873,900 - $2.01 Million	56,308 Added 52.48%	163,598 $3.1 Million
Q4 2021 Feb 08, 2022	SELL	$28.89 - $35.33 $598,629 - $732,072	-20,721 Reduced 16.19%	107,290 $3.76 Million
Q3 2021 Nov 15, 2021	SELL	$35.66 - $42.94 $445,856 - $536,878	-12,503 Reduced 8.9%	128,011 $4.69 Million
Q2 2021 Aug 11, 2021	SELL	$23.7 - $39.27 $39,318 - $65,148	-1,659 Reduced 1.17%	140,514 $5.52 Million
Q1 2021 May 13, 2021	BUY	$27.01 - $36.8 $516,917 - $704,278	19,138 Added 15.55%	142,173 $4.02 Million
Q4 2020 Feb 10, 2021	BUY	$27.51 - $34.36 $166,297 - $207,706	6,045 Added 5.17%	123,035 $3.94 Million
Q3 2020 Nov 12, 2020	SELL	$25.8 - $34.61 $1.35 Million - $1.81 Million	-52,341 Reduced 30.91%	116,990 $3.78 Million
Q2 2020 Aug 11, 2020	BUY	$17.65 - $28.05 $10,784 - $17,138	611 Added 0.36%	169,331 $4.67 Million
Q1 2020 May 12, 2020	SELL	$15.19 - $29.51 $273,693 - $531,711	-18,018 Reduced 9.65%	168,720 $3.01 Million
Q4 2019 Feb 12, 2020	SELL	$17.17 - $25.95 $95,465 - $144,282	-5,560 Reduced 2.89%	186,738 $4.68 Million
Q3 2019 Nov 12, 2019	BUY	$17.84 - $22.69 $3.43 Million - $4.36 Million	192,298 New	192,298 $3.43 Million
Q2 2019 Aug 13, 2019	SELL	$22.0 - $31.78 $196,856 - $284,367	-8,948 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$21.27 - $30.58 $190,323 - $273,629	8,948 New	8,948 $274,000

Others Institutions Holding HCM

# of Institutions

Shares Held

6.43M

Call Options Held

9.9K

Put Options Held

9.6K

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.07B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Hutchmed (China) LTD Transaction History